Screener
Medtronic MDT AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions, except share amounts) | April 24, 2026 | April 25, 2025 |
|---|---|---|
| Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,280,177,293 and 1,281,934,628 shares issued and outstanding, respectively | — | — |
| Additional paid-in capital | 20,926 | 20,833 |
| Retained earnings | 32,638 | 31,476 |
| Accumulated other comprehensive loss | (4,101) | (4,284) |
| Total shareholders’ equity | 49,463 | 48,024 |
| Noncontrolling interests | 609 | 232 |
| Total equity | 50,072 | 48,256 |
| Total liabilities and equity | $93,028 | $91,680 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's AOCI?
- Medtronic (MDT) reported AOCI of -$4.1B in Q1 2026.
- How has Medtronic's AOCI changed year-over-year?
- Medtronic's AOCI increased by 4.3% year-over-year, from -$4.28B to -$4.1B.
- What is the long-term trend for Medtronic's AOCI?
- Over 5 years (2021 to 2026), Medtronic's AOCI has grown at a 3.3% compound annual growth rate (CAGR), from -$3.49B to -$4.1B.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Medtronic's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude